IMS MAXIMS Comments on the Public Accounts Committee Hearing and NAO Report into NPfIT

IMS MAXIMSFollowing the recent UK Parliament Public Accounts Committee hearing and NAO (National Audit Office) Report, commenting Shane Tickell, CEO of UK clinical IT company IMS MAXIMS, said:

"Today's PAC committee hearing and last week's NAO report provide a damning picture of the National Programme from initial concept through to execution. By now the UK should have had among the best nationwide electronic patient record systems in the world. All that was needed was to set national standards and demand high levels of interoperability, then let trusts choose their own solution. This would have given smaller, more innovative suppliers the chance to provide hospitals with systems that worked and which met their real needs.

"Instead we seem to be in a position where - like the banks - the NPfIT contracts are seen as too big to be allowed to fail, and everyone else has to pay the price. This has left the Government trying to salvage a project which should have been abandoned, or completely re-engineered, long ago. The NHS and its patients have been severely let down.

"If the Government really wants an Information Revolution it should revitalise the drive for a nationwide electronic patient record systems and ease the terms and conditions so that bespoke suppliers in healthcare can compete, which ensures that clinicians have access to all relevant patient data in real time. There have been warm words about encouraging greater choice and creating more opportunities to new suppliers, but swift and decisive action is needed. If savings can be made from the remaining NPfIT contracts the money should be reinvested into helping trusts find the IT solutions they need. This relatively small-scale financial stimulus would do much to help patients, hospitals and the healthcare IT sector."

About IMS MAXIMS
IMS MAXIMS specialises in developing clinical and administrative software solutions and currently supports more than 100 organisations and 20,000 users of IMS MAXIMS products.

To find out more about IMS MAXIMS and its products visit www.imsmaxims.com.

Most Popular Now

Digital ECGs at Barts Health: A High-Imp…

Opinion Article by Dr Krishnaraj Sinhji Rathod, consultant in interventional cardiology, Barts Health NHS Trust. Picture the moment. A patient in an ambulance, enroute to hospital with new chest pain. Paramedics...

Study Sheds Light on Hurdles Faced in Tr…

Implementing artificial intelligence (AI) into NHS hospitals is far harder than initially anticipated, with complications around governance, contracts, data collection, harmonisation with old IT systems, finding the right AI tools...

Using Deep Learning for Precision Cancer…

Altuna Akalin and his team at the Max Delbrück Center have developed a new tool to more precisely guide cancer treatment. Described in a paper published in Nature Communications, the...

New AI Approach Paves Way for Smarter T-…

Researchers have harnessed the power of artificial intelligence (AI) to tackle one of the most complex challenges in immunology: predicting how T cells recognize and respond to specific peptide antigens...

Study Used AI Models to Improve Predicti…

Chronic kidney disease (CKD) is a complex condition marked by a gradual decline in kidney function, which can ultimately progress to end-stage renal disease (ESRD). Globally, the prevalence of the...

AI-Powered CRISPR could Lead to Faster G…

Stanford Medicine researchers have developed an artificial intelligence (AI) tool to help scientists better plan gene-editing experiments. The technology, CRISPR-GPT, acts as a gene-editing “copilot” supported by AI to help...

Groundbreaking AI Aims to Speed Lifesavi…

To solve a problem, we have to see it clearly. Whether it’s an infection by a novel virus or memory-stealing plaques forming in the brains of Alzheimer’s patients, visualizing disease processes...

AI Spots Hidden Signs of Depression in S…

Depression is one of the most common mental health challenges, but its early signs are often overlooked. It is often linked to reduced facial expressivity. However, whether mild depression or...